Spherical Nucleic Acids Deliver a New Package for Oliognucleotide Therapeutics
SNAs Are a Hopeful First Step in Boosting the Utility of Oligonucleotides to Treat a Variety of Human Diseases
Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Focus on Mid-Densities Drives Multiplex Arrays
Arrays for In vitro Diagnostics, Toxicology, Dose Response, and Biomarker Discovery
- The maturing microarray market is less about numbers than quality of information. As users complete their high-throughput, whole-genome array work, looking at hundreds of thousands of analytes, the need to focus on subsets of those analytes is building a market for mid- and low-density panels built around disease states ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.